This Million Shows Growing Confidence in 10x Genomics
A hedge fund recently boosted its position in 10x Genomics, highlighting growing confidence in the biotech tools make...
Index funds and ETFs each have roles; this note explains when index funds offer a simpler, cost-effective path for many investors.
26,830 articlesA hedge fund recently boosted its position in 10x Genomics, highlighting growing confidence in the biotech tools make...
Inside the Federal Reserve, a high-stakes power struggle quietly guides the cost of money. This tug-of-war influences...
A growing share of homeowners won’t sell price—and that stance is reshaping markets. This article explains how small ...
This week brought a sharp move in Poet Technologies shares as a dilutive financing announcement rattled investors. Le...
A mid-sized fund has quietly built a sizable Porch Group position, signaling conviction in this tech-insurance combo....
A sudden antivirus alert can look legitimate—until you realize it's a scam. This article breaks down how these tricks...
A rare fraud case shows how fake test samples led to millions in payments. Learn how it happened, what it means for y...
A high-conviction AI bet is reshaping how Ackman runs his hedge fund. Learn why nearly 40% of his capital sits in thr...
Nike has fallen 32% from its pandemic peak, boosting its dividend yield. This article weighs the dividend health, gro...
Investing in Nexpoint Residential (NXRT) hinges on understanding earnings beyond headline numbers. This guide breaks ...
A major government-backed funding signal could redefine the trajectory of this explosive quantum stock. This in-depth...
O-I Glass has climbed about 17% over the past year, even as a large fund unloaded roughly $80 million worth of stock....